STALEY CAPITAL ADVISERS’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,000
| Closed | -$63.3K | – | 188 |
|
|
2024
Q2 | $63.3K | Hold |
8,000
| – | – | ﹤0.01% | 178 |
|
|
2024
Q1 | $108K | Hold |
8,000
| – | – | 0.01% | 179 |
|
|
2023
Q4 | $86.5K | Hold |
8,000
| – | – | ﹤0.01% | 175 |
|
|
2023
Q3 | $52K | Sell |
8,000
-4,000
| -33% | -$26K | ﹤0.01% | 174 |
|
|
2023
Q2 | $216K | Hold |
12,000
| – | – | 0.01% | 166 |
|
|
2023
Q1 | $282K | Hold |
12,000
| – | – | 0.02% | 154 |
|
|
2022
Q4 | $300K | Hold |
12,000
| – | – | 0.02% | 138 |
|
|
2022
Q3 | $382K | Hold |
12,000
| – | – | 0.02% | 123 |
|
|
2022
Q2 | $474K | Hold |
12,000
| – | – | 0.03% | 118 |
|
|
2022
Q1 | $483K | Hold |
12,000
| – | – | 0.02% | 124 |
|
|
2021
Q4 | $606K | Hold |
12,000
| – | – | 0.03% | 118 |
|
|
2021
Q3 | $780K | Hold |
12,000
| – | – | 0.04% | 108 |
|
|
2021
Q2 | $465K | Hold |
12,000
| – | – | 0.02% | 127 |
|
|
2021
Q1 | $630K | Hold |
12,000
| – | – | 0.04% | 116 |
|
|
2020
Q4 | $816K | Hold |
12,000
| – | – | 0.05% | 100 |
|
|
2020
Q3 | $460K | Hold |
12,000
| – | – | 0.03% | 117 |
|
|
2020
Q2 | $464K | Buy |
12,000
+2,000
| +20% | +$77.3K | 0.03% | 111 |
|
|
2020
Q1 | $300K | Hold |
10,000
| – | – | 0.03% | 118 |
|
|
2019
Q4 | $1.14M | Buy |
10,000
+2,000
| +25% | +$227K | 0.08% | 94 |
|
|
2019
Q3 | $252K | Buy |
8,000
+4,000
| +100% | +$126K | 0.02% | 147 |
|
|
2019
Q2 | $171K | Buy |
+4,000
| New | +$171K | 0.01% | 171 |
|